Also known as Mallinckrodt, MNK.
- Study to Assess the Long-term Safety of KN3835 in the Treatment and Retreatment of Flexible/Semi-Flexible Hammertoe (HMT)RecruitingNCT07846280Phase 3
Sponsor listed in the registry: Endo USA Inc., a Keenova Therapeutics Company
- Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)RecruitingNCT07759362Phase 3
Sponsor listed in the registry: Endo USA Inc., a Keenova Therapeutics Company
- Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)CompletedNCT06151197Phase 3
Sponsor listed in the registry: Endo USA Inc., a Keenova Therapeutics Company
- Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar FibromatosisCompletedNCT05152173Phase 2
Sponsor listed in the registry: Endo USA Inc., a Keenova Therapeutics Company
- A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA)CompletedNCT06169319Phase 2
Sponsor listed in the registry: Endo USA Inc., a Keenova Therapeutics Company
- StrataGraft Overlay of Meshed Autograft in Full-thickness Thermal BurnsTerminatedNCT04765202Phase 1/2
Sponsor listed in the registry: Stratatech, a Mallinckrodt Company · First submitted after Stratatech became part of Keenova Therapeutics plc
- Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar FibromatosisCompletedNCT05254457Phase 3
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- StrataGraft Safety, Tolerability and Efficacy in Pediatric SubjectsCompletedNCT05517902Phase 3
Sponsor listed in the registry: Stratatech, a Mallinckrodt Company · First submitted after Stratatech became part of Keenova Therapeutics plc
- A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With HypogonadismCompletedNCT04456296Phase 4
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the ButtocksCompletedNCT05419505Phase 2
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's ContractureTerminatedNCT05877066
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's DiseaseTerminatedNCT05873595
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Topical Lidocaine Patch in Low Back PainCompletedNCT00904540Phase 4
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back PainCompletedNCT00904020Phase 4
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual MigraineCompletedNCT00475514Phase 3
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Vantas Implant Retrieval StudyCompletedNCT01013025
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Study of Histrelin Subdermal Implant in Patients With Prostate CancerCompletedNCT01394263Phase 3
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH)CompletedNCT04381117
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain ConditionsCompletedNCT00904202Phase 4
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute PainCompletedNCT00226395Phase 3
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant PainCompletedNCT00226421Phase 3
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate CancerCompletedNCT01697384Phase 3
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant PainCompletedNCT00225797Phase 3
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) HeadachesCompletedNCT01035983Phase 3
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual MigraineCompletedNCT00644033Phase 3
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- StrataGraft® Skin Tissue Expanded Access at Specific Study Sites ( StrataCAT )CompletedNCT04123548Phase 3
Sponsor listed in the registry: Stratatech, a Mallinckrodt Company · First submitted after Stratatech became part of Keenova Therapeutics plc
- Safety and Efficacy of EN3835 in Participants With Frozen ShoulderCompletedNCT04496167Phase 2
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)CompletedNCT03526549Phase 3
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite)CompletedNCT03632993Phase 2
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock CelluliteCompletedNCT04677712Phase 4
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Acthar Gel in Participants With Pulmonary SarcoidosisCompletedNCT03320070Phase 4
Sponsor listed in the registry: Mallinckrodt
- Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With LaxityCompletedNCT05249257
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Long-term Follow-up Durability (Efficacy) Study of EN3835 for the Treatment of AC of the Shoulder (Frozen Shoulder)TerminatedNCT04680156
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With TerlipressinCompletedNCT01143246Phase 3
Sponsor listed in the registry: Mallinckrodt
- Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1CompletedNCT02770716Phase 3
Sponsor listed in the registry: Mallinckrodt
- CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection TechniquesCompletedNCT04580303Phase 2
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Histopathology Following CCH InjectionCompletedNCT04236635Phase 2
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Real World CCH Study in Adult Females With CelluliteCompletedNCT04170296Phase 3
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric SubjectsTerminatedNCT02687451Phase 3
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult WomenTerminatedNCT04209530Phase 2
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain FunctionWithdrawnNCT04128462Phase 3
Sponsor listed in the registry: Mallinckrodt
- OCR002-SP103 - Oral Immediate Release StudyCompletedNCT03846843Phase 1
Sponsor listed in the registry: Ocera Therapeutics, Inc. · First submitted before Ocera Therapeutics, Inc. became part of Keenova Therapeutics plc
- Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)CompletedNCT01966419Phase 2
Sponsor listed in the registry: Ocera Therapeutics, Inc. · First submitted before Ocera Therapeutics, Inc. became part of Keenova Therapeutics plc
- Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric SubjectsCompletedNCT01210352Phase 3
Sponsor listed in the registry: Endo Pharmaceuticals · First submitted before Endo Pharmaceuticals became part of Keenova Therapeutics plc
- Impact of Acthar on Everyday Life of Participants With Severe KeratitisCompletedNCT04169061Phase 4
Sponsor listed in the registry: Mallinckrodt
- Acthar for Treatment-Resistant or Treatment-Intolerant ProteinuriaCompletedNCT02633046Phase 4
Sponsor listed in the registry: Mallinckrodt ARD LLC · First submitted after Mallinckrodt ARD LLC became part of Keenova Therapeutics plc
- StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin DefectsTerminatedNCT03005054Phase 2
Sponsor listed in the registry: Stratatech, a Mallinckrodt Company · First submitted after Stratatech became part of Keenova Therapeutics plc
- Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)TerminatedNCT03656692Phase 4
Sponsor listed in the registry: Mallinckrodt
- Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 DiseaseCompletedNCT01747135Phase 1
Sponsor listed in the registry: Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company · First submitted before Vtesse, LLC became part of Keenova Therapeutics plc
- MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)CompletedNCT03712280Phase 2
Sponsor listed in the registry: Mallinckrodt